Garber Alan M

CIK 00013129072 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001312907

Recent Transactions

50 trades

Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-05-01+1,199→ 1,199 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-05-01+398→ 6,872 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2024-05-01+3,142→ 3,142 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2024-03-21$19.57/sh+23,491→ 54,908 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2024-03-21$24.01/sh−19,205→ 35,703 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-03-21−23,491→ 0 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-06-01+44,087→ 44,087 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2023-05-01+1,741→ 1,741 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2023-05-01+584→ 6,474 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-02-21−40,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2023-02-21$17.49/sh−40,000→ 31,417 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2023-02-21$6.30/sh+40,000→ 71,417 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2022-05-26+42,422→ 42,422 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2022-05-01+4,462→ 4,462 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2022-03-01−40,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2022-03-01$21.00/sh−21,301→ 31,417 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2022-03-01$3.13/sh+40,000→ 52,718 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2021-05-27+33,549→ 33,549 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2021-05-01+6,067→ 6,067 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2021-03-15−40,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2021-03-15$23.60/sh−40,000→ 12,718 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2021-03-15$3.38/sh+40,000→ 52,718 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2020-06-01+2,264→ 2,264 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2020-06-01+699→ 5,890 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2020-05-22$24.42/sh−36,111→ 12,718 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2020-05-21+30,750→ 30,750 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2020-02-14$21.02/sh−12,500→ 48,829 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2020-01-07−30,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2020-01-07$18.01/sh−86,956→ 61,329 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2020-01-07$4.58/sh+30,000→ 91,329 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2020-01-07−56,956→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2020-01-07$5.82/sh+56,956→ 148,285 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2019-06-01+3,330→ 3,330 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2019-06-01+1,191→ 5,191 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2019-05-23+42,641→ 42,641 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2019-04-01$5.92/sh+15,000→ 76,329 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2019-04-01$23.97/sh−15,000→ 61,329 total
Sale
EXELIXIS, INC.$EXEL
Option (right to buy)
2019-04-01−15,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Option (right to buy)
2019-04-01−15,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2019-04-01$24.00/sh−15,000→ 61,329 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2019-04-01$4.57/sh+15,000→ 76,329 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2019-01-08−11,250→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2019-01-08$4.16/sh+11,250→ 72,579 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2019-01-08$23.00/sh−11,250→ 61,329 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2018-06-01+3,229→ 3,229 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2018-06-01+1,801→ 4,000 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2018-05-24+31,167→ 31,167 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2018-04-16−15,000→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2018-04-16$20.25/sh−15,000→ 61,329 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2018-04-16$11.66/sh+15,000→ 76,329 total

Companies

Recent Filings

Address

C/O EXELIXIS, INC. 249 EAST GRAND AVE., PO BOX 511

SOUTH SAN FRANCISCO, CA, 94083-0511

View on SEC.gov